Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Start-Ups To Once Again Play Starring Role at MEDICA 2024

By LabMedica International staff writers
Posted on 07 Nov 2024
Print article
Image: Trophies of the MEDICA START-UP COMPETITION (Photo courtesy of Constanze Tillmann)
Image: Trophies of the MEDICA START-UP COMPETITION (Photo courtesy of Constanze Tillmann)

The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62 countries from Armenia to China and America to Rwanda. They will be exhibiting their innovative solutions on the MEDICA INNOVATION FORUM stage as part of MEDICA (Düsseldorf, Germany), the leading international trade fair for the healthcare and medical equipment industries to be held in Düsseldorf from 11 to 14 November 2024.

At the MEDICA INNOVATION FORUM alone, more than 120 luminaries – including global players such as Microsoft, HP, HTC, 3M, Roche, Huawei, and KUKA – will be showcasing and discussing groundbreaking innovations and best practices. Key topics will include generative AI and big data, robotics, XR and digital twins, mobile health and medical wearables, 3D printing, the Internet of Medical Things and solutions for the hospitals of the future. The MEDICA INNOVATION FORUM will also provide a meeting place and networking platform, “Women Leaders in Healthcare.” With this year’s record participation of 60 young businesses, the MEDICA START-UP PARK will be offering visiting professionals the opportunity to familiarize themselves with a host of other exciting health start-ups and their innovations.

This year’s top 12 health techpreneurs will be presenting their solutions in the pitch final at the 16th Healthcare Innovation World Cup. This will take place on stage at the MEDICA INNOVATION FORUM, where speakers will showcase the next generation of smart health devices, medical wearables, XR solutions, digital biomarkers, electroceuticals, and smart bandages. Finalists Saventic Health, U-Care Medical Srl, and IQONIC.AI are all in on artificial intelligence. Saventic uses AI to detect rare diseases, U-Care to improve clinical outcomes in intensive care units, and IQONIC.AI provides AI-supported dermatology solutions for analyzing skin conditions and issuing personalized treatment recommendations based on advanced imaging technology.

The robotics category will be represented in the final by Robota, Robeauté, and Goodbot. Specifically, Robeauté is supporting the medical profession by supplying neurosurgical micro-robots. Robota offers an automated system for sterilizing surgical instruments, while Goodbot provides an innovative pipetting robot. Doctorderma, Vertify GmbH, and PharmaTrail AG will present their health apps. PharmaTrail develops digital solutions to streamline and optimize clinical trial management to improve efficiency and data accuracy in pharmaceutical research. AGED Diagnostics, Fepod Oy Ltd., and Dxcover are focused on laboratory diagnostics. For example, Dxcover will present an innovative liquid biopsy technology for the early detection of cancer via a simple blood test.

At an exciting onstage program, 3D printing will be the subject of discussion, before attention turns to innovative prosthetics, orthotics, and similar applications. The future of therapy will also be the center of attention at the forum. The series of talks will run the gamut from digital tools for home patient care to robot-assisted surgery, rehabilitation, and assistive technologies. The final day at the MEDICA INNOVATION FORUM will include an international flavor, with healthcare hubs from Finland, France, Germany, Taiwan, and Japan presenting their organizations. This will also offer a perfect segue into the MEDICA START-UP PARK near the forum stage. In this space, start-ups from all over the world – including Germany, Italy, India, Japan, Taiwan, Switzerland, and the United States – will be putting their innovations for healthcare on show.

Related Links:
MEDICA

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.